fluorodeoxyglucose f18 has been researched along with dacarbazine in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (17.65) | 29.6817 |
| 2010's | 46 (67.65) | 24.3611 |
| 2020's | 10 (14.71) | 2.80 |
| Authors | Studies |
|---|---|
| Brock, CS; Evans, H; Matthews, J; Newlands, ES; O'Reilly, SM; Osman, S; Price, PM; Young, H | 1 |
| Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Weihrauch, MR; Wolf, J | 1 |
| Argiris, A; Mellott, A; Spies, S | 1 |
| Chan, V; Chaudhry, AA; Clark, CT; Daw, HA; Kundranda, MN | 1 |
| Barnett, CM; Brock, C; Bydder, GM; Charnley, N; Glaser, M; Matthews, J; Newlands, ES; Price, P; Swindell, R; West, CM | 1 |
| Bomanji, J; Buchler, T; Lee, SM | 1 |
| Bomanji, J; Buchler, T; Edwards, SG; Lee, SM; Ramsay, A | 1 |
| Subbiah, V | 1 |
| Radford, J | 1 |
| Czerminski, J; LaCasce, AS; Mauch, PM; Ng, AK; Sher, DJ; Van Den Abbeele, A | 1 |
| Endo, K; Higuchi, T; Kuji, I; Matsuda, H; Murakami, K; Nakajima, K; Oriuchi, N; Tsukamoto, N | 1 |
| Kuruvilla, J | 1 |
| Buccheri, V; Cerci, JJ; Delbeke, D; Izaki, M; Linardi, CC; Meneghetti, JC; Pitella, FA; Pracchia, LF; Soares, J; Trindade, E | 1 |
| Brown, PD; Buckner, JC; Galanis, E; Giannini, C; Jaeckle, KA; McGraw, S; Peller, PJ; Sarkaria, JN; Uhm, JH; Wu, W | 1 |
| Argnani, L; Baccarani, M; Broccoli, A; Castagnoli, A; Fanti, S; Puccini, B; Rigacci, L; Stefoni, V; Vaggelli, L; Zanoni, L; Zinzani, PL | 1 |
| Bolacchi, F; Danieli, R; Della Gatta, F; Gaspari, E; Mancini, A; Orlacchio, A; Ragano Caracciolo, C; Schillaci, O; Simonetti, G | 1 |
| Bower, M; Cwynarski, K; Fields, P; Marcus, R; McNamara, C; Montoto, S; Okosun, J; Shaw, K; Virchis, A; Warbey, V | 1 |
| Illés, A; Jóna, A; Lieber, A; Miltényi, Z; Páyer, E; Simon, Z; Szilasi, M | 1 |
| Cantonetti, M; Caracciolo, CR; Chiaravalloti, A; Danieli, R; Di Pietro, B; Pagani, M; Schillaci, O; Simonetti, G; Tavolozza, M; Travascio, L | 1 |
| Barré, L; Bernaudin, M; Corroyer-Dulmont, A; Delamare, J; Divoux, D; Guillamo, JS; Ibazizène, M; Jacobs, AH; Lecocq, M; MacKenzie, ET; Pérès, EA; Petit, E; Roussel, S; Toutain, J; Valable, S; Varoqueaux, N | 1 |
| Hartridge-Lambert, SK; Lim, RC; Maragulia, JC; Portlock, CS; Schöder, H | 1 |
| Burger, IA; Goldman, DA; Gonen, M; Hricak, H; Kumar, A; Schöder, H; Vargas, HA; Zelenetz, AD | 1 |
| Faber, C; Jacobs, AH; Kopka, K; Kuhlmann, M; Schäfers, M; Schelhaas, S; Schwegmann, K; Viel, T; Wachsmuth, L; Wagner, S | 1 |
| Chong, A; Chung, JS; Hong, JS; Jeong, SY; Kim, JH; Kim, SJ; Lee, JJ; Lee, SM; Moon, JH; Shin, HJ; Song, MK | 1 |
| Choi, YW; Kim, J; Lee, M; Lee, O; Oh, C; Park, G | 1 |
| Amitani, R; Ariyasu, R; Hanaoka, K; Inada, S; Konishi, Y; Nagano, H; Nakagawa, K; Nakamura, Y; Nishizaka, Y; Okamoto, N; Taki, M; Tsudo, M; Wakasa, T; Wakayama, T; Yoshida, M; Yoshimura, C | 1 |
| Bodell, MA; Kraus, ES; Lipson, EJ; Sharfman, WH | 1 |
| Abbatiello, P; Cantonetti, M; Chiaravalloti, A; Danieli, R; Di Pietro, B; Guazzaroni, M; Orlacchio, A; Schillaci, O; Simonetti, G; Travascio, L | 1 |
| Alavi, A; Goncalves, MD; Torigian, DA | 1 |
| Aaløkken, TM; Bogsrud, TV; Geier, OM; Hagtvedt, T; Holte, H; Lund, KV; Løndalen, AM; Seierstad, T; Smith, HJ | 1 |
| Alberini, JL; Aupérin, A; Bonniaud, G; Celebic, A; Edeline, V; Elleuch, M; Fermé, C; Girinsky, T; Ribrag, V; Ruelle, C | 1 |
| Biggi, A; Coleman, M; Czuczman, MS; Danielewicz, I; Diehl, L; Hutchings, M; Kostakoglu, L; Lamonica, D; Loft, A; Malkowski, B; Nanni, C; Specht, L; Stern, R; Zaucha, JM; Zinzani, PL | 1 |
| Dieckmann, K; Kluge, R; Körholz, D; Mauz-Körholz, C; Vordermark, D | 1 |
| Ahmad, MW; Alken, S; Colleran, GC; Fitzpatrick, D; Kavanagh, EC; Kelly, CM; Lyons, TG; Murray, B; O'Kane, GM | 1 |
| Gandikota, N; Hartridge-Lambert, S; Migliacci, JC; Portlock, CS; Schöder, H; Yahalom, J | 1 |
| Akhtar, S; Alhuraiji, A | 1 |
| Cavalli, F; Ceriani, L; Griguolo, G; Mazzucchelli, L; Stathis, A; Zucca, E | 1 |
| Botto, B; Buglione, M; Ciammella, P; Filippi, AR; Iotti, C; Livi, L; Magrini, SM; Merli, F; Re, A; Ricardi, U; Saieva, C; Simontacchi, G; Vaggelli, L | 1 |
| Chiba, S; Fujishima, F; Hasegawa, Y; Ichinohasama, R; Ito, Y; Kurita, N; Kyogoku, C; Miyamoto, K; Nakamura, S; Obara, N; Ogawa, S; Sakata-Yanagimoto, M; Seki, M; Yokoyama, Y | 1 |
| Cassou-Mounat, T; Cayssials, E; Delwail, V; Puyade, M; Terroir, M | 1 |
| Abruzzese, E; Bocchia, M; Bono, R; Bosi, A; Cencini, E; Cox, MC; Di Lollo, S; Di Napoli, A; Fabbri, A; Fratoni, S; Gini, G; Goteri, G; Kovalchuk, S; Lazzi, S; Leoncini, L; Mancuso, S; Rigacci, L | 1 |
| Apel, A; Avigdor, A; Ben-Bassat, I; Dann, EJ; Davidson, T; Kedmi, M; Levi, I; Nagler, A; Polliack, A | 1 |
| Almquist, H; Barrington, SF; Berkahn, L; Brun, E; D'Amore, F; Federico, M; Fosså, A; Franceschetto, A; Fulham, MJ; Hjorthaug, K; Johnson, PW; Kirkwood, AA; Luminari, S; Molin, D; O'Doherty, MJ; Pike, LC; Radford, J; Roberts, TH; Sinclair, DA; Smith, P; Stevens, L; Trotman, J; Viney, ZN | 1 |
| Caocci, G; Carcassi, C; Caria, R; Celeghini, I; Di Raimondo, F; Gallamini, A; Greco, M; La Nasa, G; Lai, S; Littera, R; Martino, M; Oppi, S; Porcella, R; Romano, A | 1 |
| Bisi, G; Botto, B; Buglione, M; Ciammella, P; Filippi, AR; Iotti, C; Mangoni, M; Marcheselli, L; Merli, F; Ricardi, U; Simontacchi, G; Versari, A | 1 |
| Barr, PM; Bartlett, NL; Cheson, BD; Cook, JR; Evens, AM; Fanale, MA; Fisher, RI; Friedberg, JW; Gascoyne, RD; Hsi, ED; Kahl, BS; Knopp, MV; LaCasce, AS; LeBlanc, M; Lechowicz, MJ; Leonard, JP; Li, H; Mittra, ES; Moskowitz, CH; Noy, A; Press, OW; Rimsza, LM; Schöder, H; Straus, DJ; Sweetenham, JW | 1 |
| Danilov, AV; Friedberg, JW; Li, H; Noy, A; Press, OW; Reid, E; Shapira, I; Smith, SM; Swinnen, LJ | 1 |
| Bordenave, L; Bouabdallah, K; Cazeau, AL; Guyot, M; Hindié, E; Mesguich, C; Milpied, N; Soubeyran, P | 1 |
| Akhtari, M; Chuang, H; Dabaja, BS; Dong, W; Fanale, M; Garg, N; Gunther, JR; Khoury, JD; Mawlawi, O; Milgrom, SA; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Rohren, E; Smith, GL; Suki, T; Yehia, ZA | 1 |
| Cheson, BD; Kostakoglu, L | 1 |
| Chen, YH; Jacene, HA; Kamran, SC; Mauch, PM; Ng, AK | 1 |
| Adams, HJA; Kwee, TC | 3 |
| Dabaja, BS; Fanale, M; Gunther, JR; Milgrom, SA; Pinnix, CC | 1 |
| Dinh, T; Olshen, AB; Pampaloni, MH; Phelps, AS; Robbins, E; Stieglitz, E | 1 |
| Aquino-Parsons, C; Bénard, F; Connors, JM; Farinha, P; Gascoyne, RD; Gerrie, AS; Morris, J; Pickles, T; Savage, KJ; Scott, DW; Sehn, LH; Slack, GW; Tonseth, P; Villa, D; Wilson, D | 1 |
| Deyell, RJ; Eftekhari, A; Ingley, KM; Nadel, HR; Potts, JE; Wilson, DC | 1 |
| Beyhan Sagmen, S; Comert, S; Doğan, C; Fidan, A; Kıral, N; Küçüköz Uzun, A; Torun Parmaksız, E; Turan Erkek, E; Yılmaz Haksal, Ç; Yılmaz, G | 1 |
| Ansell, SM; Botto, B; Habermann, TM; Inwards, DJ; Johnston, PB; Micallef, IN; Novo, M; Nowakowski, GS; Ristow, KM; Vitolo, U; Witzig, TE; Young, JR | 1 |
| Bonfichi, M; Botto, B; Broccoli, A; Dona, M; Evangelista, A; Gioia, D; Gotti, M; Kovalchuk, S; Mannelli, L; Nassi, L; Pagani, C; Puccini, B; Pulsoni, A; Re, A; Rigacci, L; Salvi, F; Santoro, A; Spina, M; Stelitano, C; Zinzani, PL | 1 |
| Cappuccio, I; Del Vecchio, S; Della Pepa, R; Fonti, R; Giordano, C; Mainolfi, C; Mascolo, M; Nicolai, E; Pane, F; Picardi, M; Pugliese, N; Rascato, MG; Salvatore, M; Troncone, G; Venetucci, P; Vigliar, E | 1 |
| Bai, C; Cheng, Y; Guan, M; Jia, N; Xing, J; Ying, H | 1 |
| Buvat, I; Ciarrocchi, A; Ciavarella, S; Cottereau, AS; Donati, B; Durmo, R; Luminari, S; Meignan, M; Merli, F; Nioche, C; Nizzoli, ME; Rebaud, L; Ruffini, A; Vegliante, MC; Versari, A | 1 |
| Al-Ibraheem, A; Almasri, N; Anwer, F; Halahleh, K; Jaradat, I; Juweid, ME; Khalaf, AN; Ma'koseh, M; Mansour, A; Obeidat, S; Shagera, QA | 1 |
| Barrington, SF; Dunn, JT; Duran, A; Ilyas, H; Mikhaeel, NG; Mir, N; Subesinghe, M | 1 |
| Bergesio, F; Bianchi, A; Biggi, A; Chauvie, S; Chiaravalloti, A; Fallanca, F; Gallamini, A; Gregianin, M; Guerra, L; La Nasa, G; Menga, M; Patti, C; Pavoni, C; Picardi, M; Rambaldi, A; Romano, A; Schiavotto, C; Schillaci, O; Sorasio, R; Trentin, L; Viviani, S | 1 |
| Gallamini, A; Gastaud, L; Kurlapski, M; Sudria, A | 1 |
3 review(s) available for fluorodeoxyglucose f18 and dacarbazine
| Article | Year |
|---|---|
Standard therapy of advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2009 |
FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine | 2017 |
Systemic treatment of a metastatic carotid body tumor: A case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Carotid Body Tumor; Cyclophosphamide; Dacarbazine; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vincristine | 2020 |
12 trial(s) available for fluorodeoxyglucose f18 and dacarbazine
| Article | Year |
|---|---|
Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radiopharmaceuticals; Temozolomide; Tomography, Emission-Computed | 2000 |
18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Vinblastine; Young Adult | 2010 |
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Everolimus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sirolimus; Temozolomide | 2011 |
Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin's lymphoma?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; Brain; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Vinblastine | 2013 |
Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diffusion Magnetic Resonance Imaging; Doxorubicin; Early Diagnosis; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; Diaphragm; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphatic Irradiation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Vinblastine; Young Adult | 2014 |
Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiation Injuries; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Vinblastine; Young Adult | 2014 |
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Vinblastine; Vincristine; Young Adult | 2016 |
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; HIV Seropositivity; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Treatment Outcome; Vinblastine | 2017 |
ABVD Without Radiation for Newly Diagnosed Pediatric and Young Adult Patients With Hodgkin Lymphoma: A Single Center Retrospective Analysis of 28 Consecutive Patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Vinblastine | 2018 |
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autografts; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prospective Studies; Stem Cell Transplantation; Survival Rate; Vinblastine | 2020 |
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Reproducibility of Results; Treatment Outcome; Vinblastine | 2023 |
53 other study(ies) available for fluorodeoxyglucose f18 and dacarbazine
| Article | Year |
|---|---|
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Etoposide; False Negative Reactions; False Positive Reactions; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Mediastinal Neoplasms; Melphalan; Neoplasm Recurrence, Local; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Transplantation, Autologous; Vinblastine; Vincristine | 2001 |
PET scan assessment of chemotherapy response in metastatic paraganglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carotid Body Tumor; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Primary malignant melanoma of the lung: a case report and review of the literature.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dacarbazine; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Temozolomide; Tomography, X-Ray Computed | 2006 |
Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Temozolomide; Treatment Outcome | 2006 |
FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Middle Aged; Pneumonia; Positron-Emission Tomography; Vinblastine | 2007 |
Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult.
Topics: Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Disease Progression; Doxorubicin; Fluorodeoxyglucose F18; HIV Infections; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Thymus Gland; Treatment Outcome; Vincristine | 2008 |
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Sarcoidosis; Vinblastine | 2008 |
Limited-stage disease: optimal use of chemotherapy and radiation treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Radiotherapy; Risk Assessment; Vinblastine | 2008 |
Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed; Vinblastine | 2009 |
[Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Rituximab; Vinblastine; Vincristine; Young Adult | 2009 |
Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Time Factors; Vinblastine; Young Adult | 2012 |
Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2012 |
Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2012 |
[Diagnostic difficulties caused by a pulmonary infiltrate].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; Fever of Unknown Origin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2012 |
Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers; Brain Neoplasms; Dacarbazine; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunoenzyme Techniques; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Survival Rate; Temozolomide; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiation Monitoring; Radiography; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Young Adult | 2013 |
The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Procarbazine; Retrospective Studies; Sperm Count; Testis; Tomography, X-Ray Computed; Vinblastine; Vincristine; Young Adult | 2013 |
Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.
Topics: Animals; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Brain Neoplasms; Dacarbazine; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Injections, Intraventricular; Injections, Subcutaneous; Mice; Mice, Nude; Neoplasms, Experimental; Temozolomide; Tomography, Emission-Computed; Treatment Outcome; Tumor Burden | 2013 |
Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Vinblastine; Young Adult | 2013 |
Efficacy of oregonin investigated by non-invasive evaluation in a B16 mouse melanoma model.
Topics: Animals; Antineoplastic Agents; Antioxidants; Dacarbazine; Diarylheptanoids; Fluorodeoxyglucose F18; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Neoplasm Transplantation; Neoplasms, Experimental; Plant Extracts; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Anaplastic large cell lymphoma mimicking fibrosing mediastinitis.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Diagnostic Errors; Doxorubicin; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Lymphoma, Large-Cell, Anaplastic; Mediastinitis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Sclerosis; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2013 |
Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Dacarbazine; Drug Administration Schedule; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Ipilimumab; Kidney Transplantation; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Mycophenolic Acid; Platinum Compounds; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Skin Neoplasms; Tacrolimus; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma.
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Liver; Male; Mediastinum; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vinblastine | 2014 |
FDG-PET/CT assessment of differential chemotherapy effects upon skeletal muscle metabolism in patients with melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Muscle, Skeletal; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Temozolomide; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Vinblastine; Young Adult | 2014 |
Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Colitis; Dacarbazine; Fluorodeoxyglucose F18; Humans; Ipilimumab; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Multimodal Imaging; Myelitis; Paraplegia; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Temozolomide; Tomography, X-Ray Computed | 2014 |
Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Diagnostic Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Vinblastine; Young Adult | 2015 |
Untreated Hodgkin Lymphoma With Skin Infiltration and Satellite Skin Nodule in a 15-Year-Old Female Adolescent.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed; Vinblastine | 2015 |
A case of Hodgkin lymphoma in a patient with a history of bone pain and an initial diagnosis of chronic osteomyelitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Density Conservation Agents; Bone Marrow; Bone Neoplasms; Chronic Disease; Dacarbazine; Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Osteoblasts; Osteomyelitis; Pain; Pleural Effusion; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sacrum; Tomography, X-Ray Computed; Treatment Failure; Vinblastine | 2015 |
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Regression Analysis; Remission Induction; Retrospective Studies; Time Factors; Vinblastine | 2015 |
Complete Remission in Systemic Skin Interdigitating Dendritic Cell Sarcoma after ABVD Chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Dendritic Cell Sarcoma, Interdigitating; Doxorubicin; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Immunophenotyping; Male; Middle Aged; Positron-Emission Tomography; Remission Induction; Skin; Skin Neoplasms; Vinblastine | 2015 |
Use of temozolomide instead of cyclophosphamide in diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Dacarbazine; Drug Hypersensitivity; Drug Substitution; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Recurrence; Temozolomide; Treatment Outcome; Young Adult | 2016 |
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Vinblastine; Young Adult | 2017 |
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2016 |
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine | 2016 |
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Gene Frequency; Haplotypes; HLA Antigens; Hodgkin Disease; Homozygote; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Receptors, KIR; Vinblastine | 2016 |
Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Vinblastine; Young Adult | 2016 |
Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Management; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Treatment Failure; Treatment Outcome; Vinblastine; Young Adult | 2016 |
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Glycolysis; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Recurrence; Risk; Treatment Outcome; Tumor Burden; Vinblastine | 2017 |
Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; In Vivo Dosimetry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Young Adult | 2018 |
The predictive value of interim FDG-PET in early-stage Hodgkin lymphoma is not well established.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Poland; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine | 2018 |
Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma: response to Adams and Kwee.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Vinblastine | 2019 |
Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Vinblastine | 2019 |
Strikingly Heterogeneous Results Among Studies on Interim Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment in Advanced-Stage Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Vinblastine | 2018 |
Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiotherapy Dosage; Vinblastine; Young Adult | 2018 |
The Utility of PET/CT in Guiding Radiotherapy Reduction for Children With Hodgkin Lymphoma Treated With ABVD.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Radiotherapy, Image-Guided; Retrospective Studies; Survival Rate; Vinblastine; Young Adult | 2020 |
Can We Predict Bleomycin Toxicity with PET-CT?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Vinblastine | 2019 |
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine | 2020 |
2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Management; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Vinblastine; Young Adult | 2020 |
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Genomics; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Retrospective Studies; RNA; Vinblastine | 2022 |
Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Vinblastine | 2022 |
The frequency of change in five-point scale score with a Bayesian penalised likelihood PET reconstruction algorithm on interim FDG PET-CT and its potential implications for therapy decisions in Hodgkin's lymphoma.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine | 2023 |
Revisiting the predictive role of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography on treatment outcome in early-stage favorable Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Treatment Outcome; Vinblastine | 2023 |